Announcements Trials
Browse Landscape

Phase

Phase 3 3Phase 2 2

Status

Recruiting 4Active not recruiting 1

Sponsor Class

OTHER 3NETWORK 1INDUSTRY 1

Study Type

Interventional 5

Sponsor

Cancer Type

Head & Neck 5

Conditions

Prostatic Neoplasms 12Glioblastoma 11Carcinoma, Non-Small-Cell Lung 9Breast Neoplasms 8Oropharyngeal Neoplasms 7Lung Neoplasms 6Squamous Cell Carcinoma of Head and Neck 5Neoplasms 5Burkitt Lymphoma 5Astrocytoma 5Urinary Bladder Neoplasms 4Carcinoma 4Adenocarcinoma of Lung 4Sarcoma 3Rhabdomyosarcoma, Embryonal 3Rhabdomyosarcoma 3Rectal Neoplasms 3Pancreatic Neoplasms 3Neoplasm Metastasis 3Nasopharyngeal Carcinoma 3Mouth Neoplasms 3Laryngeal Neoplasms 3Hodgkin Disease 3Gliosarcoma 3Glioma 3Triple Negative Breast Neoplasms 2Small Cell Lung Carcinoma 2Rhabdomyosarcoma, Alveolar 2Prostate Adenocarcinoma 2Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 2

Interventions

pembrolizumab 33Cisplatin 22Carboplatin 16Magnetic Resonance Spectroscopy 15Specimen Handling 12Cetuximab 12Radiotherapy, Intensity-Modulated 11Paclitaxel 9Platinum 8Nivolumab 81,2-diaminocyclohexaneplatinum II citrate 8atezolizumab 5Taxes 5Radiotherapy 5Docetaxel 5Biopsy 5Fluorouracil 4(225)Ac-DOTA-c(RGDyK) 4dostarlimab 3cemiplimab 3Radiotherapy, Image-Guided 3Radiation 3Fulvestrant 3Bevacizumab 3tislelizumab 2dehydroftorafur 2budigalimab 2amivantamab 2abemaciclib 2Tiragolumab 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Squamous Cell Carcinoma of Head and Neck × Radiotherapy × 30 days × Clear all
NCT07497607 2026-05-18

REDUCE-30

University of Cincinnati

Phase 2 Recruiting
31 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck

NCT04892173 2026-05-11

JNJ-90301900 (NBTXR3) Activated by Radiotherapy With or Without Cetuximab in LA-HNSCC

Johnson & Johnson Enterprise Innovation Inc.

Phase 3 Recruiting
500 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Squamous Cell

NCT06992427 2026-05-11

HOPE

Alliance for Clinical Trials in Oncology

Phase 3 Recruiting
228 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck

NCT05721755 2026-05-05

Combining Radiation Therapy With Immunotherapy for the Treatment of Metastatic Squamous Cell Carcinoma of the Head and Neck

Eastern Cooperative Oncology Group

Phase 3 Active not recruiting
290 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Hypopharyngeal Neoplasms, Laryngeal Neoplasms, Mouth Neoplasms, Oropharyngeal Neoplasms

NCT07040956 2026-05-04

A Clinical Trial Comparing Low-Dose RT + Targeted Therapy+ Immunotherapy vs Targeted Therapy+ Immunotherapy Alone as Neoadjuvant Therapy in Operable HNSCC Patients.

West China Hospital

Phase 2 Recruiting
98 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck

Data powered by HemOnc (CC BY 4.0) Colophon âš¡